Popcorn lung is a serious condition in which the tiniest airways in your lungs become scarred and narrowed, making it progressively harder to breathe. Its medical name is bronchiolitis obliterans. The nickname comes from a cluster of cases discovered in 2000 at a Missouri microwave popcorn factory, where eight workers developed severe, irreversible lung disease from inhaling butter-flavoring chemicals on the job.
What Happens Inside the Lungs
Your lungs branch into smaller and smaller tubes, ending in tiny passages called bronchioles. In popcorn lung, these bronchioles become inflamed and trigger an abnormal healing response. Instead of repairing normally, the tissue fills in with scar tissue and excess smooth muscle, narrowing the airway. In some cases, the scarring completely blocks the passage.
This scarring is what makes popcorn lung different from conditions like asthma. In asthma, the airways tighten temporarily and respond to inhalers. In popcorn lung, the narrowing is structural, caused by physical scar tissue rather than muscle spasms. Bronchodilator medications do little to open these airways back up. The damage also stays confined to the small airways and doesn’t spread to the air sacs deeper in the lung where oxygen exchange happens, which is one reason it can be tricky to detect early. Researchers estimate that roughly 75% of all small airways need to be obstructed before standard breathing tests even pick up a problem.
Causes and Risk Factors
The most well-known cause is inhaling diacetyl, a chemical that gives microwave popcorn and other foods their buttery flavor. After the Missouri popcorn factory cases prompted investigation, the CDC confirmed diacetyl as the culprit. The flavoring industry later introduced a substitute chemical called 2,3-pentanedione, but animal studies have shown it causes similar respiratory damage. NIOSH, the federal agency responsible for workplace safety research, has estimated that over a thousand flavoring chemicals are potential respiratory hazards.
Chemical exposure isn’t the only path to popcorn lung. Other causes include:
- Lung transplant: About 1 in 2 lung transplant recipients develop popcorn lung within five years, making it one of the leading long-term complications of the procedure. The body’s immune response to the transplanted tissue triggers the same scarring process in the bronchioles.
- Bone marrow transplant: Roughly 1 in 10 people who receive donor bone marrow develop popcorn lung within five years.
- Autoimmune diseases: Conditions like rheumatoid arthritis can cause the immune system to attack the small airways, leading to the same type of scarring.
- Toxic fumes: Industrial chemicals, chlorine gas, ammonia, and other inhaled toxins can all damage the bronchioles severely enough to set off the fibrotic healing response.
The Vaping Connection
Diacetyl and similar flavoring chemicals have been found in some e-cigarette liquids, which raised alarm that vaping could cause popcorn lung. This concern is reasonable in principle: heating and inhaling the same chemical known to destroy factory workers’ lungs is clearly risky. But as of the most recent medical literature, there are no confirmed, biopsy-proven cases of bronchiolitis obliterans caused by vaping.
One widely cited 2019 case in Canada involved a teenager whose symptoms looked consistent with popcorn lung after heavy e-cigarette use. However, the medical team could not obtain the type of tissue sample needed to confirm the diagnosis, and the exact chemical responsible was never identified. The case remains suggestive but unproven. This doesn’t mean vaping is safe for your lungs. It means the specific link to popcorn lung hasn’t been definitively established the way it has for factory workers breathing diacetyl fumes for hours a day.
Symptoms and How They Develop
Popcorn lung often starts silently. You may have no symptoms at all in the early stages, partly because the small airways contribute so little to overall airflow resistance that significant damage can accumulate before you notice anything wrong.
When symptoms do appear, they typically include:
- Shortness of breath, especially during or after physical activity
- A dry cough that worsens with exertion
- Wheezing
- Persistent fatigue
These symptoms overlap heavily with asthma and COPD, which is one reason popcorn lung is frequently misdiagnosed. The key distinction is that popcorn lung doesn’t improve with standard asthma treatments. If you’re using an inhaler and getting no relief, that poor response to bronchodilators is itself a diagnostic clue. In people with occupational exposure, symptoms may develop weeks to months after the initial contact with the chemical. In transplant recipients, the timeline stretches to months or years.
How It’s Diagnosed
Diagnosing popcorn lung usually involves a combination of breathing tests, imaging, and sometimes a lung biopsy. Pulmonary function tests show a pattern of airflow limitation that doesn’t improve when you inhale a bronchodilator, distinguishing it from asthma. The tests may also reveal air trapping, where your lungs can’t fully empty because the narrowed airways act like one-way valves.
A high-resolution CT scan of the chest can reveal a characteristic “mosaic” pattern, with patches of lung that look different depending on how well air is flowing through them. This pattern, combined with the breathing test results and a history of chemical exposure or transplant, often points to the diagnosis. A surgical lung biopsy, which shows the classic scarring and narrowing of the bronchioles under a microscope, provides the most definitive confirmation, but it isn’t always safe or practical to perform.
Treatment and Outlook
The scarring in popcorn lung is permanent. There is no treatment that reverses the fibrosis once it forms. The primary goal of treatment is to slow or stop further damage and manage symptoms.
The first and most important step is removing the source of injury. For workers, that means eliminating or drastically reducing exposure to diacetyl and similar chemicals. NIOSH recommends that employers keep diacetyl and 2,3-pentanedione levels below established exposure limits using ventilation, enclosed production processes, and respiratory protection. For transplant recipients, treatment focuses on adjusting the immune-suppressing medications that manage the body’s rejection response.
Anti-inflammatory medications, including corticosteroids, are commonly used to reduce ongoing inflammation in the airways. Some patients also receive antibiotics that have anti-inflammatory properties in the lungs. These treatments can stabilize the condition or slow its progression, but results vary widely. Some people remain stable for years, while others continue to decline despite treatment. For the most severe cases, where lung function has deteriorated to the point of respiratory failure, lung transplantation becomes the remaining option, though it carries the ironic risk of popcorn lung developing again in the new lungs.